Skip to main content
. Author manuscript; available in PMC: 2024 Feb 14.
Published in final edited form as: Circulation. 2023 Feb 13;147(7):e76–e91. doi: 10.1161/CIR.0000000000001124

Table 3.

Tailored Interventions to Promote Cardiovascular Health at Various Pre-Pregnancy Life Stages and Across Ecological Levels

Pre-Pregnancy Life Stages
People with no current intention to become pregnant
(Includes adolescents)
graphic file with name nihms-1888492-t0001.jpg People with intention to become pregnant
(pre-pregnancy)
graphic file with name nihms-1888492-t0002.jpg People with intention to become pregnant again
(inter-pregnancy)
graphic file with name nihms-1888492-t0003.jpg
Individual
  • Lifestyle coaching

  • Stress reduction

  • Sleep interventions

  • Weight loss pharmacotherapy/bariatric surgery

  • Text-based interventions

In addition to those for people with no current intention to become pregnant,
  • Lifestyle-based weight loss interventions

  • Pharmacotherapy safe during pregnancy to achieve optimal risk factor control

  • Lifestyle-based interventions for people with a history of APOs

  • Pharmacotherapy among individuals after a history of APOs (e.g., metformin or GLP-1RA after gestational diabetes)

  • Cognitive behavioral therapy and pharmacologic therapy for postpartum depression

Community
  • Civic engagement

  • Peer-led support groups

  • Peer-led parenting groups

  • Home visiting programs focused on stress, postpartum depression

Population
  • Social marketing campaigns to raise awareness about CVH promotion

  • Built environment changes (e.g., access to healthy foods, green spaces)

Policy
  • Dismantle structural racism

  • Fair housing practices

  • Access to education, equitable employment opportunities, and paid family leave

  • Healthcare workforce diversity

  • Continuous health insurance coverage to ensure high-quality pre-pregnancy counseling and minimize interruptions in access

APOs adverse pregnancy outcomes; CVH cardiovascular health; GLP-1RA glucagon-like peptide-1 receptor agonists; SNAP supplemental nutrition assistance program; WIC Special supplemental nutrition program for women, infants, and children;